Cargando…

Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients

OBJECTIVES: To investigate prognostic-related gene signature based on DNA damage repair and tumor microenvironment statue in human papillomavirus 16 negative (HPV16-) head and neck squamous cell carcinoma (HNSCC). METHODS: For the RNA-sequence matrix in HPV16- HNSCC in the Cancer Genome Atlas (TCGA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Tang, Ling-Long, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241267/ https://www.ncbi.nlm.nih.gov/pubmed/35768785 http://dx.doi.org/10.1186/s12885-022-09722-x

Ejemplares similares

Correction: Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients
por: Li, Jing, et al.
Publicado: (2022)

A HPV16-related prognostic indicator for head and neck squamous cell carcinoma
por: Zhang, Qian, et al.
Publicado: (2020)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
por: Lechien, Jérôme R., et al.
Publicado: (2020)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity
por: Nickson, Catherine M., et al.
Publicado: (2017)

Hydroperoxidation of Docosahexaenoic Acid by Human ALOX12 and pigALOX15-mini-LOX
por: Canyelles-Niño, Miquel, et al.
Publicado: (2023)

Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer
por: Wang, Zhongqiu, et al.
Publicado: (2023)

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
por: Benavente, Sergi
Publicado: (2023)

Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
por: Cochicho, Daniela, et al.
Publicado: (2021)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Targeting DNA Double-Strand Break Repair Enhances Radiosensitivity of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma to Photons and Protons
por: Vitti, Eirini Terpsi, et al.
Publicado: (2020)

Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients
por: Hotz, Alrun, et al.
Publicado: (2021)

TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation
por: Dixit, Ronak, et al.
Publicado: (2015)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients
por: Jiarpinitnun, Chuleeporn, et al.
Publicado: (2020)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma
por: O’Neill, W. Quinn, et al.
Publicado: (2022)

Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma
por: Zhou, Qimin, et al.
Publicado: (2022)

Pyroptosis patterns influence the clinical outcome and immune microenvironment characterization in HPV-positive head and neck squamous cell carcinoma
por: Li, Doudou, et al.
Publicado: (2023)

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16
por: Biesaga, Beata, et al.
Publicado: (2017)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
por: Chantre-Justino, Mariana, et al.
Publicado: (2022)

The Antiviral Agent Cidofovir Induces DNA Damage and Mitotic Catastrophe in HPV-Positive and -Negative Head and Neck Squamous Cell Carcinomas In Vitro
por: Verhees, Femke, et al.
Publicado: (2019)

Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
por: Zhou, Ziyuan, et al.
Publicado: (2012)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zeitlin, Ross, et al.
Publicado: (2015)

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
por: Augustin, Jeremy Gbenakpon, et al.
Publicado: (2020)

Analysis of the anatomical distribution of HPV genotypes in head and neck squamous papillomas
por: Hu, Huiying, et al.
Publicado: (2023)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
por: Aggarwal, Charu, et al.
Publicado: (2015)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing
por: Nichols, Anthony C., et al.
Publicado: (2012)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma
por: Ma, Xiangrui, et al.
Publicado: (2017)

Targeted inhibition of BET proteins in HPV-16 associated head and neck squamous cell carcinoma reveals heterogeneous transcription response
por: Rao, Aakarsha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7lk7rqjg1vb0n9ugb4137fjcr4